Unsupervised clustering reveals diverse subgroups in systemic sclerosis, suggesting personalized medicine may enhance patient stratification strategies.
Unsupervised clustering and proteomic profiling reveal biologically distinct subgroups within SSc, beyond traditional clinical or serological classifications. Our findings support the integration of molecular tools into patient stratification strategies, paving the way toward personalized medicine in SSc.
No takes yet. Share an insight, caveat, or question.
R. Ortega Castro (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: